摘要
鼻疽是类鼻疽的病原体和代表潜在的生物恐怖威胁。在这项研究中,使用人巨噬细胞的模型B杆菌感染的转录反应进行了调查全基因组微阵列。基因表达谱感染的THP-1人单核细胞白血病细胞用或不用圆斑(DRRDbTx)或头孢他啶(抗生素对照)治疗之间进行比较。感染的和经处理的细胞显示的各种炎性基因,如白介素-1(IL-1),IL-6,肿瘤坏死因子-α(TNF-α),环氧合酶(COX-2),血管内皮生长差动上调的微阵列分析因子(VEGF),趋化因子CXC基序配体4(CXCL4),转录因子p65的(NF-kB的);和参与免疫和应激反应,细胞周期,和脂质代谢的几个基因。此外,以下的DRR-DbTx治疗感染的细胞,有增强的tolllike受体2(TLR-2)参与识别和急性炎症反应引发介导的信号传导途径的表达。重要的是,我们观察到高度的炎性细胞因子基因的反应是在感染细胞24小时后暴露在与DRR DbTx或头孢他啶类似。此外,还有增加的细胞死亡蛋白酶激活,可以促进宿主组织损伤。总之,在巨噬细胞的B杆菌感染的转录反应突出广泛的在24小时后感染激活先天性免疫机制。这些数据提供深入了解以下DRR-DbTx治疗感染B杆菌的人巨噬细胞的转录动力学。
关键词: 类鼻疽杆菌,基因表达,促炎因子,人类巨噬细胞,毒液蛋白
Current Molecular Medicine
Title:Gene Microarray Analyses of Daboia russelli russelli Daboiatoxin Treatment of THP-1 Human Macrophages Infected with Burkholderia pseudomallei.
Volume: 15 Issue: 10
Author(s): R. Perumal Samy, J. Manikandan, A. Pachiappan, E.E. Ooi, L.T. Aw, B.G. Stiles, O.L. Franco, M. Kandasamy, K.M. Mathi, G. Rane, K.S. Siveen, C. Arunachalam, M.E. Zayed, S.A. Alharbi and A.P. Kumar, G. Sethi, L.H.K. Lim and V.T. Chow
Affiliation:
关键词: 类鼻疽杆菌,基因表达,促炎因子,人类巨噬细胞,毒液蛋白
摘要: Burkholderia pseudomallei is the causative agent of melioidosis and represents a potential bioterrorism threat. In this study, the transcriptomic responses of B. pseudomallei infection of a human macrophage cell model were investigated using whole-genome microarrays. Gene expression profiles were compared between infected THP-1 human monocytic leukemia cells with or without treatment with Daboia russelli russelli daboiatoxin (DRRDbTx) or ceftazidime (antibiotic control). Microarray analyses of infected and treated cells revealed differential upregulation of various inflammatory genes such as interleukin-1 (IL-1), IL-6, tumor necrosis factor-alpha (TNF-α), cyclooxygenase (COX-2), vascular endothelial growth factor (VEGF), chemokine C-X-C motif ligand 4 (CXCL4), transcription factor p65 (NF-kB); and several genes involved in immune and stress responses, cell cycle, and lipid metabolism. Moreover, following DRR-DbTx treatment of infected cells, there was enhanced expression of the tolllike receptor 2 (TLR-2) mediated signaling pathway involved in recognition and initiation of acute inflammatory responses. Importantly, we observed that highly inflammatory cytokine gene responses were similar in infected cells exposed to DRR-DbTx or ceftazidime after 24 h. Additionally, there were increased transcripts associated with cell death by caspase activation that can promote host tissue injury. In summary, the transcriptional responses during B. pseudomallei infection of macrophages highlight a broad range of innate immune mechanisms that are activated within 24 h post-infection. These data provide insights into the transcriptomic kinetics following DRR-DbTx treatment of human macrophages infected with B. pseudomallei.
Export Options
About this article
Cite this article as:
R. Perumal Samy, J. Manikandan, A. Pachiappan, E.E. Ooi, L.T. Aw, B.G. Stiles, O.L. Franco , M. Kandasamy, K.M. Mathi, G. Rane, K.S. Siveen, C. Arunachalam, M.E. Zayed, S.A. Alharbi and A.P. Kumar, G. Sethi, L.H.K. Lim and V.T. Chow , Gene Microarray Analyses of Daboia russelli russelli Daboiatoxin Treatment of THP-1 Human Macrophages Infected with Burkholderia pseudomallei., Current Molecular Medicine 2015; 15 (10) . https://dx.doi.org/10.2174/1566524016666151123114123
DOI https://dx.doi.org/10.2174/1566524016666151123114123 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis, Characterization and Evaluation of pH-sensitive Polyacrylamide- g-acacia Gum Microspheres for Colon Targeted Drug Delivery Application
Drug Delivery Letters Selective Inhibition of Animal DNA Polymerases by Fat-Soluble Vitamins A,D, E and K and Their Related Compounds
Current Enzyme Inhibition An Updated Patent Therapeutic Agents Targeting MMPs
Recent Patents on Anti-Cancer Drug Discovery MALT Lymphoma, Stress Ulcer and Cholinergic Nerves from the Viewpoint of Bilateral and Unilateral Truncal Vagotomy and Substance P
Current Pharmaceutical Design RGD Peptide–mediated Molecular Imaging for Targeting Integrin Alpha(v) Beta(3) in Tumors: A Review
Current Medical Imaging Virtual Screening Against Obesity
Current Medicinal Chemistry Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Integrative System Biology Strategies for Disease Biomarker Discovery
Combinatorial Chemistry & High Throughput Screening Therapeutic Potential of Plant Extracts and Phytochemicals Against Brain Ischemia-Reperfusion Injury: A Review
The Natural Products Journal Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract
Current Neuropharmacology Metal Complexes of Natural Product Like-compounds with Antitumor Activity
Anti-Cancer Agents in Medicinal Chemistry Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Current Medicinal Chemistry Editorial (Thematic Issue: From Gut Inflammation to Gastrointestinal Disorders Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities)
Current Pharmaceutical Design Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS Metastases: The Road less Travelled
Current Molecular Pharmacology Mucosal Immunisation: Adjuvants and Delivery Systems
Current Drug Delivery Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies
Current Topics in Medicinal Chemistry Strategies to Overcome Multi-Drug Resistance in Cancer Cells: the Contribution of siRNA and Nanotechnologies
Current Organic Chemistry Medications not Intended for Treatment of Dyslipidemias and with a Variable Effect on Lipids
Current Pharmaceutical Design The Role of Phenolic Compounds in the Fight against Cancer – A Review
Anti-Cancer Agents in Medicinal Chemistry Curcumin: A Natural Pan-HDAC Inhibitor in Cancer
Current Pharmaceutical Design